ARTLVSNRSN• 28 Days (Normalized)
ARTL vs NRSN (Artelo Biosciences Inc. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Sep 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
+%
Artelo Biosciences Inc.
Normalized Baseline0.00%
NRSN Performance $4.78
+1063.02%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
-1063.02 pts
NRSN outperforming by 1063.02 percentage points
ARTLNRSN
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | ARTL Price | ARTL Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $4.78 | +1063.02% | - | |
| Sep 28, 2026 | $- | $5.10 | +1140.88% | - | |
| Sep 25, 2026 | $4.54 | -30.37% | $6.95 | +1591.00% | -1621.37% |
| Sep 24, 2026 | $5.17 | -20.71% | $7.40 | +1700.49% | -1721.20% |
| Sep 23, 2026 | $7.31 | +12.12% | $7.40 | +1700.49% | -1688.37% |
| Sep 22, 2026 | $4.15 | -36.35% | $7.18 | +1646.96% | -1683.31% |
| Sep 21, 2026 | $4.10 | -37.12% | $6.62 | +1510.71% | -1547.83% |
| Sep 18, 2026 | $3.94 | -39.57% | $6.35 | +1445.01% | -1484.58% |
| Sep 17, 2026 | $3.97 | -39.11% | $6.72 | +1535.04% | -1574.15% |
| Sep 16, 2026 | $3.75 | -42.48% | $6.49 | +1479.08% | -1521.56% |
| Sep 15, 2026 | $5.34 | -18.10% | $7.03 | +1610.46% | -1628.56% |
| Sep 14, 2026 | $4.87 | -25.31% | $6.90 | +1578.83% | -1604.14% |
| Sep 11, 2026 | $5.43 | -16.72% | $0.35 | -15.57% | -1.15% |
| Sep 10, 2026 | $5.63 | -13.65% | $0.33 | -19.22% | +5.57% |
| Sep 09, 2026 | $5.98 | -8.28% | $0.40 | -2.43% | -5.85% |
Page 1 of 2